Our vision is a world where every person, everywhere benefits from timely access to safe, effective, and quality-assured medicines and other health products, including innovative products and emerging technologies, to attain the highest possible level of health and well-being.
Our mission is to facilitate access to safe, effective and quality-assured medicines and health products to achieve universal health coverage goals through the provision of evidence-based normative guidance, standards, specifications, policy and technical assistance to Member States. The scope of our work covers assistive technology; biologicals and biological products (including cell and gene therapies); blood products; internationally-controlled medicines and substances; medical devices, including in vitro diagnostics; medicines; and organs, tissues and cell transplantation.
Contact information
Featured
News
All →Expert Committees
Advisory groups
Databases
Publications
All →Journal articles
Identifying and costing common gaps in Central and West Africa pharmaceutical regulation
The World Health Organization Global Benchmarking Tool an Instrument to Strengthen Medical Products Regulation and Promote Universal Health Coverage
A pilot programme to teach pharmacology using the international nonproprietary names in a pharmacy school in Spain
Meeting reports
Uzbekistan: Reimbursatsiya dasturiga kiritiladigan kasalliklar va ularni davolashda beriladigan dori vositalari roʻyxatini tasdiqlash to‘g‘risida 2026 (Uzbek)
South Africa: Essential Medicines List 2024 (English)
INN Recommended List 96
Nigeria: Essential Medicines list 2024 (English)
United Republic of Tanzania: National Essential Medicines List (NEMLIT) 2026 (English)
Executive Summary of the WHO Implementation Workshop in the Western Pacific region: Revised WHO Guidelines on Evaluation of Biosimilars
Trainings
Multimedia